Acceptable file formats: PDF, EPS, AI

G2® Premium Gel Roller Pen - Breast Cancer Awareness (0.7mm)
#G2 IG2-7 BCA

Pricing Details

Production Time: 7 Working Days
QuantityPrice
200 $2.26 each
500 $2.16 each
1000 $1.89 each
2500 $1.65 each
5000 $1.60 each
AABCC
  • G2 is America's #1 selling, longest lasting, smooth writing gel ink pen brand
  • Features pink ribbon imprint, grip & clip
  • Vibrant, quick drying Gel ink
  • Available in Fine point (0.7mm)
  • Pink and Black ink colors
Description
Product Details

  • G2 has been proven to last longer than the average of competitive Gel ink brands
  • Pink ribbon imprint shows your support for Breast Cancer Awareness
  • Pilot will donate 10% of its gross proceeds from each pink ribbon product sold, up to $130,000, to the National Breast Cancer Foundation
  • Contoured, latex-free rubber grip conforms to your writing grasp providing maximum comfort

Imprint Methods

    SCREEN PRINTING
  • Setup: $30.00(G) per color
  • Run Charge: $0.10(G) each pen per additional color
  • Imprint Area: 1 1/2" x 3/8"


    UV/4-COLOR PROCESS
  • Setup: $35.00(G)
  • No Run Charge
  • Imprint Area: 2" x 1/4"

Production

  • Less Than Minimum: 125 pieces, $30.00 (G)
  • Packaging: Bulk
  • Normal Production Time:
    - 5 business days for repeat orders
    - 7 business days for new orders after credit and artwork approval

Normal Production Time
7 Working Days

Country of Manufacture
Japan

Additional Information
Pilot will donate 10% of its gross proceeds from each pink ribbon product sold from 1/1/2024 through 12/31/2028, up to $130,000, to the National Breast Cancer Foundation for breast cancer education, support and early detection. For more information, please visit www.nbcf.org.

AdoptCode.png     We Are     Sage 2024     DC     PPEF

ASI: 78110 | DC: 100360  |  PPAI: 112712 | SAGE: 53144 | UPIC: PILOT1 

Pilot_Logo_white.png

Copyright © 2015 Pilot Corporation of America. All Rights Reserved.

This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. Contact Us with any questions or search this site for more information.